Kevin Li
Angel Investor @ Frazier Life Sciences
Palo Alto, United States
Kevin Li is a Series C investor at Frazier Life Sciences in Palo Alto focused on Biopharma and Biotechnology. Kevin Li is based out of Westlake Village, California and is the Partner of Frazier Life Sciences and Board of Director of Angitia Biopharmaceuticals. Kevin Li attended Yale University.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Kevin Li invests in
Stages Kevin Li invests in
Countries Kevin Li invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biopharma 2 (67%)
- Biotechnology 2 (67%)
- Medical 1 (33%)
- Health Care 1 (33%)
- Pharmaceutical 1 (33%)
Stage
- Series C 1 (33%)
- Series D 1 (33%)
- Post-IPO Equity 1 (33%)
Country
- China 1 (33%)
- Canada 1 (33%)
- Sweden 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. | $130M / Series D / Feb 05, 2026 | ||
| 35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need. | $53M / Series C / Nov 26, 2024 | ||
| Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development. | $15.8M / Post-IPO Equity / Oct 10, 2023 |
Co-Investors
About Frazier Life Sciences
Frazier Life Sciences IX is a venture capital fund. Frazier Life Sciences invests in and builds companies developing and commercializing novel therapeutics at all stages, from company formation to public.
Frazier Life Sciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Tao Fu
Venture Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Kevin Li invest in?
Kevin Li invests primarily in Biopharma, Biotechnology and Medical startups, most often at Series C and Series D stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kevin Li?
Public channels for Kevin Li include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kevin Li last invest?
The most recent investment recorded for Kevin Li closed in Feb 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
